(210116) -- ANKARA, Jan. 16, 2021 -- A medical worker receives a dose of China s Sinovac COVID-19 vaccine at the Sabiha Uzun Maternal Child Health Center in Ankara, Turkey on Jan. 15, 2021. More than 600,000 health workers in Turkey have received their first doses of COVID-19 shots developed by China s Sinovac during the first two days of the country s vaccination program, Turkish Health Ministry s data showed on Friday. (Photo by Xinhua) TURKEY-ANKARA-HEALTH WORKER-COVID-19-VACCINATION MustafaxKaya

(210116) -- ANKARA, Jan. 16, 2021 -- A medical worker receives a dose of China s Sinovac COVID-19 vaccine at the Sabiha Uzun Maternal Child Health Center in Ankara, Turkey on Jan. 15, 2021. More than 600,000 health workers in Turkey have received their first doses of COVID-19 shots developed by China s Sinovac during the first two days of the country s vaccination program, Turkish Health Ministry s data showed on Friday. (Photo by Xinhua) TURKEY-ANKARA-HEALTH WORKER-COVID-19-VACCINATION MustafaxKaya

Choose your license

Rights Managed:

One-time editorial use in an online article, social media channels, internal presentation, website, newsletter, or blog.

One-time editorial use in a book, newspaper or magazine (excluding cover page), external presentation. Limited to 5,000 circulation. This includes the rights available in the Standard license.

Media Info

Credit: Xinhua

Media ID:

Recording Date: Jan 15, 2021

Media Size: 3,000×2,133 Pixels

(210116) -- ANKARA, Jan. 16, 2021 -- A medical worker receives a dose of China s Sinovac COVID-19 vaccine at the Sabiha Uzun Maternal Child Health Center in Ankara, Turkey on Jan. 15, 2021. More than 600,000 health workers in Turkey have received their first doses of COVID-19 shots developed by China s Sinovac during the first two days of the country s vaccination program, Turkish Health Ministry s data showed on Friday. (Photo by Xinhua) TURKEY-ANKARA-HEALTH WORKER-COVID-19-VACCINATION MustafaxKaya

Restrictions: This image can not be published in China.

Release Info: Do I need a release?

Captions may have been translated or enriched by an AI system.
For more information about AI-assisted captions, see AI-assisted captions.

Need a custom license?

If your intended use isn't covered by the available options (such as non-editorial purposes or specific distribution needs), contact us. Our team will be happy to provide a tailored offer based on your requirements.